Furthermore, both the tumor weight–normalized cell number and the percentage of TAMs among myeloid cells in the RT + αPD-1 + CCR2/5i group were reduced significantly compared with the RT + αPD-1 group. The gene discussed is CCR2; the disease is neoplasm.